ABVC BIOPHARMA INC's ticker is ABVC and the CUSIP is 00091F106. A total of 5 filers reported holding ABVC BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $201,313 | -18.8% | 387,513 | 0.0% | 0.00% | – |
| Q1 2023 | $248,008 | +5.7% | 387,513 | +3.2% | 0.00% | – |
| Q4 2022 | $234,696 | -28.9% | 375,513 | +0.1% | 0.00% | – |
| Q3 2022 | $330,000 | -17.1% | 375,142 | 0.0% | 0.00% | – |
| Q2 2022 | $398,000 | -61.1% | 375,142 | 0.0% | 0.00% | – |
| Q1 2022 | $1,024,000 | -19.0% | 375,142 | +0.6% | 0.00% | – |
| Q4 2021 | $1,264,000 | +1244.7% | 372,760 | +819.0% | 0.00% | – |
| Q3 2021 | $94,000 | – | 40,560 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VANGUARD GROUP INC | 375,142 | $1,024,000 | 0.00% |
| UBS Group AG | 1,274 | $3,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 49,915 | $136,000 | 0.00% |
| MORGAN STANLEY | 1,460 | $4,000 | 0.00% |